Cardiogenic Shock From Chronic Immune Checkpoint Inhibitor Associated Myocarditis Causing Predominant Right Ventricular Failure

Key Result

Chronic immune checkpoint inhibitor-associated myocarditis can cause cardiogenic shock presenting as predominant right ventricular failure.

Key Points

• The study aims to evaluate the relationship between immune checkpoint inhibitors and the onset of myocarditis leading to right ventricular failure.
• Analysis of cases involving immune checkpoint inhibitors and myocarditis
• Assessment of cardiac function focusing on right ventricular parameters
• Monitoring patient outcomes in context of myocarditis onset and ventricular performance.
• Identified a notable incidence of right ventricular failure in patients with myocarditis due to immune checkpoint inhibitors
• Found a significant correlation between myocardial dysfunction and decreased right ventricular ejection fraction
• Noted adverse outcomes resulting in cardiogenic shock in affected patients.